Results

Total Results: 658 records

Showing results for "mentioned".

201. Disposition of Comments for Treatments for Fibromyalgia in Adult Subgroups (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_disposition-comments.pdf
     January 26, 2015 - that illustrates the risk of bias for each study needs to be mentioned here. … We read the mentioned article prior to the posting of this report draft. … While this is mentioned under Applicability and Limitations of the Evidence Base, it should be included … Also, short term evidence was mentioned on pg. 41 of Research Gaps. … The second study mentioned by the Reviewer (Arnold et al., Pain Med 2007) was excluded due to the short

202. Disposition of Comments Report for Technical Brief 15 Transition Care for Children With Special Health Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
     June 17, 2014 - Throughout the document, as has been mentioned previously, the focus of the document has been on the … Again, as has been mentioned previously, there are differing levels of evidence cited throughout this … & Affiliation Section Comment Response Reviewer 7 (TEP) Background- Guiding Questions As mentioned … As mentioned, elements of the adult literature might have been missed if the search terms included items … Reviewer 11 (TEP) General – Clarity and Usability Except for the minor problems mentioned under

203. Disposition of Comments for Pulmonary Arterial Hypertension: Screening, Management, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
     April 25, 2013 - CTEPH is mentioned twice, suggesting 2 studies are being cited, but not clear in the sentence. … Although the limitation of only 1 study is mentioned and SOE is rated low, the overall message relayed … The specific observational studies mentioned by the reviewer were considered but not analyzed: - … We have mentioned the limitations in assessing left heart filling pressures by echocardiography. … The specific echo parameters mentioned (mean tricuspid regurgitation gradient, diastolic regurgitation

204. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
     June 07, 2013 - TEP Member 2 Executive Summary (ES 16-17) Table G last row is mortality from stroke--not mentioned in … text but mentioned for Table H which does not include mortality and mentions 2 studies??

205. Executive Summary_Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
     August 01, 2024 - Low Note: Remaining comparisons not mentioned in the table received an insufficient grade.

206. Disposition of Comments_Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disposition-comments.pdf
     April 10, 2025 - preschool 0-3 years, 0- 5 years and Elementary to Middle school , Middle school to High school as mentioned … Pediatrics 4 Results Page 36: 3.1.3.16.2 Detailed Analysis, Second paragraph: Was child welfare mentioned

207. Disposition of Comments Report for Whole-Body Vibration Therapy for Osteoporosis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-vibration-therapy_disposition-comments.pdf
     November 15, 2011 - Peer Reviewer #1 Background In the last paragraph of the introduction, it is mentioned that WBV may … We have mentioned the development of this new technology.

208. Using Deliberative Methods to Engage Patients, Consumers, and the Public (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/deliberative-methods-how-to-webinar-text-only.pdf
     December 06, 2011 - Further, education is a defining feature of deliberation, as I mentioned previously. … Key features of methods include the length, mode (in person or online), group size, as I just mentioned … As Ela mentioned, you’ll want to determine whether you will evaluate your approach and how you will

209. Using Deliberative Methods to Engage Patients, Consumers, and the Public (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/deliberative-methods-how-to-webinar-text-only.pdf
     December 06, 2011 - Further, education is a defining feature of deliberation, as I mentioned previously. … Key features of methods include the length, mode (in person or online), group size, as I just mentioned … As Ela mentioned, you’ll want to determine whether you will evaluate your approach and how you will

210. Disposition of Comments for Local Nonsurgical Therapies for Stage I and Symptomatic Obstructive Non-Small-Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_disposition-comments.pdf
     June 12, 2013 - Section Comment Response Reviewer 2 (TEP) Results These are complete and well done although as mentioned … 27] In table 4 and table 7 the percentage refers to the percentage of studies that show the above mentioned … toxicities is evident among or across interventions, with the possible exception of rib fractures mentioned

211. Disposition of Comments Report for Decision Aids for Cancer Screening and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-decision-support-tools_disposition-comments.pdf
     December 23, 2014 - This should be mentioned in the Limitations section. … Peer Reviewer #1 Discussion/ Conclusion The authors have mentioned the likelihood of publication bias … TEP Reviewer #3 Clarity and Usability Not all other attributes in table 3 are mentioned in the methods

212. Disposition of Comments_Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-disposition-comments_0_0.pdf
     October 13, 2021 - For KQ3, we lacked enough studies to perform subgroup analyses based on any of the mentioned sociodemographic … Education, Research of Health Policy", final paragraph -- discussion regarding ICD, Revisions 9 codes are mentioned

213. Disposition of Comments: Comparative Effectiveness Review No. 232_Interventions for Breathlessness in Patients With Advanced Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-232-breathlessness-cancer-comments.pdf
     November 19, 2020 - This may be in addition to the theory mentioned above with TRPM8 channels. … We have clarified baseline dyspnea and defined hypoxemia at each point it is mentioned in tables. … We have clarified baseline dyspnea and defined hypoxemia at each point it is mentioned in tables.

214. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - This technology might be mentioned on page 5 of Chapter 1, where new dosage forms are mentioned, eg … Peer Reviewer 7 Results: Chapter 3- KQ 1 As mentioned in the method section, though methods for … Summary and Discussion: Chapter 4- Discussion/Conc lusion Testing for publication bias is not mentioned … Russell, Graham Summary and Discussion: Chapter 4- Discussion Denosumab is rightly mentioned as … 4- Discussion Serious skin infections (cellulitis) is listed in PI as FDA warning and should be mentioned

215. Disposition of Comments_Systematic Review: The Relationship of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-disposition-comments_0.pdf
     March 03, 2025 - Disposition of Comments_Systematic Review: The Relationship of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition Systematic Review Disposition of Comments Report Title: Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabete…

216. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - It should be clearly mentioned that the CYP2C19 genotype is in fact a surrogate marker of the latter … We have mentioned that several possibilities exist for incorporating testing in clinical practice, in … In addition, there is some evidence (also mentioned by the reviewers’ in preceding comments) that the … We have explicitly mentioned the need to consider the tradeoff between harms and benefits of testing … Our principal suggestion is that more detail about the methodological issues mentioned above be included

217. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
     May 01, 2013 - However, the Two- Question screen is not mentioned/described immediately before or after Table A. … A limitation of the CER should be mentioned. … SER on PPD treatment) but would like it mentioned now. … ES-18 and elsewhere in the document: cost is mentioned. 2 issues: it is unclear whether it's the cost … ES_19 re risk factors: are the risk factors being mentioned valid?

218. Disposition of Comments Report for Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
     February 26, 2013 - These findings are already mentioned in the report. … While FAME II is mentioned in the “Ongoing Research” section of the report, we recommend that the report … future, we urge that AHRQ update this comparative effectiveness review with the clinical studies mentioned

219. Disposition of Comments for Interventions for Adolescents and Young Adults With Autism Spectrum Disorders (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_disposition-comments.pdf
     August 27, 2012 - As mentioned earlier Kazdin himself has probably done more RCT studies than anyone in the field of … interventions may be better served as their own category--and "facilitated" communication should be mentioned

220. Research Protocol (Amended): Treatment of Acute Pain--An Evidence Map (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-protocol-amended.pdf
     June 10, 2018 - identify systematic reviews on pain treatments for acute pain for the priority acute pain conditions mentioned … reviews published 2016 forward in English, aim to evaluate treatment for the acute pain conditions mentioned